Biotechnology Research startups in South San Francisco

Neurona Therapeutics

South San Francisco

Neurona Therapeutics is a biotherapeutics company that focuses on developing cell-based therapies to address neurological disorders.

Encoded Therapeutics

South San Francisco

Encoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.

Tizona Therapeutics

South San Francisco

Tizona develops next-generation immunotherapies

Axys Pharmaceuticals

South San Francisco

AXYS Pharmaceuticals is engaged in the discovery and development of therapeutic small molecules.

Trace Neuroscience

South San Francisco

Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients.

Lycia Therapeutics

South San Francisco

Lycia is a Series B biotech company built on a platform developed by academic founder Professor Carolyn Bertozzi at Stanford, arising from Stanford research, with potential to deliver next-generation therapeutics for difficult-to-treat dise

Atomic AI

South San Francisco

Atomic AI uses AI and structural biology to redesign molecules, with an R&D platform built on Science-cover research to target RNA structure and tackle undruggable diseases, guided by an interdisciplinary computational and experimental biol

NewLimit

South San Francisco

NewLimit is a biotechnology company developing medicines to treat age-related diseases by reprogramming the epigenome to restore regenerative potential in aged and diseased cells. It uses functional genomics, pooled perturbation screens, an

ReviR Therapeutics

South San Francisco

ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.

GenEdit

South San Francisco

GenEdit tackles delivery challenges in genetic medicines using its NanoGalaxy platform, a library of thousands of non-viral, polymer nanoparticles. Through iterative screening it identifies nanoparticles that deliver payloads to target tiss

Frontier Medicines

South San Francisco

Frontier Medicines is a precision medicine company with offices in South San Francisco and Boston that uses chemoproteomics, covalent drug discovery, and machine learning to target disease-causing proteins previously undruggable; its lead p

Culture Biosciences

South San Francisco

Culture is a cloud-based bioreactor lab that accelerates bioprocess development by letting customers design experiments and have Culture execute them in its high-throughput bioreactor cloud lab, with real-time data monitoring and analytics

Federation Bio

South San Francisco

Federation Bio is a microbial therapeutics company targeting diseases in which the human microbiome can play a curative role.

Ambys Medicines

South San Francisco

Ambys Medicines is focused on unlocking the full potential of hepatocyte transplantation and transforming the treatment of severe liver disease.

Tenaya Therapeutics

South San Francisco

Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.

Alpine Bio

South San Francisco

We are an ingredient innovation company pioneering new forms of purification and biomanufacturing to liberate ingredients from legacy constraints across functionality, flavor, bioactivity, and sustainability.

Epicrispr Biotechnologies

South San Francisco

South San Francisco-based · biotechnology research.

Mission Bio

South San Francisco

Mission Bio solves complex biological problems using precision engineering, innovative biochemistry, and supported bioinformatics. Spun out from UCSF in 2014, it leverages Adam Abate’s droplet microfluidics to unlock single-cell biology for

Twist Bioscience

South San Francisco

Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries.

Abdera Therapeutics

South San Francisco

Abdera Therapeutics Inc. is a precision oncology company developing next-generation targeted radiation therapies using a modular platform to deliver radioisotopes to selectively destroy tumor cells while sparing healthy tissue, enabling rap

Vilya

South San Francisco

Vilya is a computational biotechnology company creating a novel class of medicines by exploring uncharted chemical space within cyclic peptides and designing new structures with advanced computing; co-founded by IPD scientists led by David

Electra Therapeutics

South San Francisco

A unique vision on mastering SIRP.

Catalyst Biosciences

South San Francisco

Catalyst is a research and clinical development biopharmaceutical company focused on addressing unmet medical needs in rare disorders of the complement and coagulation systems.